Mechanical or metabolic treatment for coronary disease: Synergistic, not antagonistic, approaches

Cardiology in Review

Volumn 10, Issue 3, 2002, Pages 182-187

  Gemayel, Carol ^a   Waters, David ^a  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

Cholesterol; Coronary angioplasty; Revascularization; Statins

Indexed keywords

ATORVASTATIN; HYPOCHOLESTEROLEMIC AGENT;

ANGINA PECTORIS; ANGIOCARDIOGRAPHY; CARDIOLOGY; CLINICAL TRIAL; CORONARY ARTERY DISEASE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERCHOLESTEROLEMIA; INTERVENTIONAL RADIOLOGY; MEDICAL SPECIALIST; MORTALITY; REVIEW;

EID: 0036303533     PISSN: 10615377     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045415-200205000-00007     Document Type: Review

References (18)

1. Qualitative and quantitative comparison of amounts of narrowing by atherosclerotic plaques in the major epicardial coronary arteries at necroscopy in sudden coronary death, transmural acute myocardial infarction, transmural healed myocardial infarction and unstable angina pectoris
2. Coronary artery narrowing in coronary heart disease: Comparison of cineangiographic and necroscopy findings
3. Atherosclerosis in angiographically "normal" coronary artery reference segments: An intravascular ultrasound study with clinical correlations
4. Coronary plaque disruption
5. Cholesterol lowering trials in coronary heart disease: Frequency of citation and outcome
6. Scandinavian Simvastatin Survival Study Group: Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
7. The effect of provastatin on coronary events after myocardial infarction in patients with average cholesterol levels
8. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
9. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
10. Primary prevention of accute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS
11. Plaque stabílization: A mechanism for the beneficial effect of lipid-lowering therapies in angiographic studies
12. Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease: A potential noninvasive marker of healing coronary endothelium
13. Effect of cholesterol reduction on myocardial ischemia in patients with coronary disease
14. Early statin treatment following acute myocardial infarction and 1-year survival
15. Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: An observational study
16. Cholesterol lowering: Should it continue to be the last thing we do?
17. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: The MIRACL study: A randomized controlled trial
18. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease